March 18, 2021
TB Alliance and GSK announce partnership to develop new TB therapeutics
Partnership between pharmaceutical firm and non-profit product development partnership seeks to identify and advance new compounds to achieve breakthroughs in TB treatment
February 1, 2021
ZebiAI and TB Alliance Announce Collaboration to Apply ML-Driven Discovery Platform to Tuberculosis Targets
TB Alliance to leverage ZebiAI’s platform to discover novel probe compounds for important tuberculosis targets, with options for drug discovery
January 28, 2021
New Report Reveals that R&D Partnerships Serving Neglected Communities have Produced Dozens of Life-Saving Innovations Since 2010
Novel approach for minimizing investment risks and stretching limited budgets has 375 innovations targeting infectious diseases under development
December 14, 2020
TB Alliance Announces First Patient Dosed with TBAJ-587 in Phase 1 Study
Study seeks to further develop a new compound to treat patients with tuberculosis
December 8, 2020
Patients in South Africa to Access Six-Month, All-Oral Treatment for Highly Drug-Resistant Tuberculosis
October 30, 2020
TB Alliance is Honored to Accept the Prix Galien Award for Best Pharmaceutical Agent
October 23, 2020